The effect of dapsone on skin flap survival depends on modulation of inflammatory response and VEGF expression
![](https://article.accscience.com/imageFile/by-nc.png)
The random-pattern skin flap is a common method used for reconstructing skin defects. However, flap ischemia necrosis remains a significant challenge in plastic surgery. Strategies aimed at reducing persistent inflammation and promoting blood supply through angiogenesis have been identified as crucial for improving flap survival. Dapsone, a chemotherapeutic agent known for its anti-inflammatory properties through multiple pathways, is of interest in this regard. This study aims to investigate the effect of dapsone on random-pattern flap survival in rats, along with its impact on inflammation and angiogenesis. The ischemia/reperfusion (I/R) injury rat models were created using a caudal-based dorsal skin flap with delayed I/R. Twenty-four male Sprague Dawley rats were divided into control, sham, and two treatment groups receiving dapsone at doses of 12.5 mg/kg/day and 5 mg/kg/day, respectively. On the 7th post-operative day, flap survival was evaluated. Neutrophil infiltration and ulceration were measured through microscopic examination, and interleukin (IL)-8 levels through enzyme-linked immunosorbent assay. Expression levels of vascular endothelial growth factor (VEGF) and tumor necrosis factor-alpha (TNF-α) were determined using an immunohistochemistry (IHC) array. The findings revealed an increased flap survival on day 7 post-operation following systemic administration of dapsone for 5 consecutive days. Dapsone at both dosages significantly reduced the ulcer thickness, neutrophil infiltration, and IL-8 levels. The IHC results revealed that VEGF expression was significantly higher in the treatment groups compared to the control group. Moreover, TNF-α expression was significantly lower in the treatment groups compared to the control group. In conclusion, we confirmed that treatment with dapsone promotes skin flap survival, and this effect aligned with a reduction in persistent inflammation and the enhancement of VEGF. Nonetheless, more studies are required to elucidate the precise anti-inflammatory mechanism of dapsone in I/R injuries.
- Basu G, Downey H, Guo S, et al. Prevention of distal flap necrosis in a rat random skin flap model by gene electro transfer delivering VEGF(165) plasmid. J Gene Med. 2014;16(3-4):55-65. doi: 10.1002/jgm.2759
- Pavletic MM. Skin flaps in reconstructive surgery. Vet Clin North Am Small Anim Pract. 1990;20(1):81-103. doi: 10.1016/s0195-5616(90)50005-4
- Kruter L, Rohrer T. Advancement flaps. Dermatol Surg. 2015;41:S239-S246. doi: 10.1097/DSS.0000000000000497
- Myers BM, Cherry G. Causes of necrosis in pedicle flaps. Plast Reconstr Surg. 1968;42(1):43-50.
- Callegari PR, Taylor GI, Caddy CM, Minabe T. An anatomic review of the delay phenomenon: I. Experimental studies. Plast Reconstr Surg. 1992;89(3):397-407; discussion 417-418.
- Du Z, Zan T, Li H, Li Q. A study of blood flow dynamics in flap delay using the full-field laser perfusion imager. Microvasc Res. 2011;82(3):284-290. doi: 10.1016/j.mvr.2011.09.010
- Taylor GI, Corlett RJ, Caddy CM, Zelt RG. An anatomic review of the delay phenomenon: II. Clinical applications. Plast Reconstr Surg. 1992;89(3):408-416; discussion 417-418.
- Luo X, Zhao B, Chen B, et al. Trans-cinnamaldehyde increases random pattern flap survival through activation of the nitric oxide pathway. Drug Des Devel Ther. 2021;15:679-688. doi: 10.2147/DDDT.S297458
- Lee JH, You HJ, Lee TY, Kang HJ. Current status of experimental animal skin flap models: Ischemic preconditioning and molecular factors. Int J Mol Sci. 2022;23(9):5234. doi: 10.3390/ijms23095234
- Khalil AA, Aziz FA, Hall JC. Reperfusion injury. Plast Reconstr Surg. 2006;117(3):1024-1033. doi: 10.1097/01.prs.0000204766.17127.54
- Suzuki S, Miyachi Y, Niwa Y, Isshiki N. Significance of reactive oxygen species in distal flap necrosis and its salvage with liposomal SOD. Br J Plast Surg. 1989;42(5):559-564. doi: 10.1016/0007-1226(89)90045-3
- Abbaszadeh-Kasbi A, Haddadi NS, Dehdashtian A, et al. Acute activation of α7-nicotinic receptors by nicotine improves rodent skin flap survival through nitrergic system. Ann Plast Surg. 2019;83(2):211-216. doi: 10.1097/sap.0000000000001809
- Wilgus TA, Roy S, McDaniel JC. Neutrophils and wound repair: Positive actions and negative reactions. Adv Wound Care (New Rochelle). 2013;2(7):379-388. doi: 10.1089/wound.2012.0383
- Tanno H, Kawakami K, Kanno E, et al. Invariant NKT cells promote skin wound healing by preventing a prolonged neutrophilic inflammatory response. Wound Repair Regen. 2017;25(5):805-815. doi: 10.1111/wrr.12588
- Lan CCE, Wu CS, Huang SM, Wu IH, Chen GS. High-glucose environment enhanced oxidative stress and increased interleukin-8 secretion from keratinocytes: New insights into impaired diabetic wound healing. Diabetes. 2013;62(7):2530-2538. doi: 10.2337/db12-1714
- Qazi BS, Tang K, Qazi A. Recent advances in underlying pathologies provide insight into interleukin-8 expression-mediated inflammation and angiogenesis. Int J Inflam. 2011;2011:908468. doi: 10.4061/2011/908468
- He JB, Fang MJ, Ma XY, Li WJ, Lin DS. Angiogenic and anti-inflammatory properties of azadirachtin A improve random skin flap survival in rats. Exp Biol Med (Maywood). 2020;245(18):1672-1682. doi: 10.1177/1535370220951896
- Fan W, Liu Z, Chen J, et al. Effect of memantine on the survival of an ischemic random skin flap and the underlying mechanism. Biomed Pharmacother. 2021;143:112163. doi: 10.1016/j.biopha.2021.112163
- Vourtsis SA, Papalois AE, Agrogiannis GD, Spyriounis PK, Patsouris E, Ionac M. Improvement of a long random skin flap survival by application of vascular endothelial growth factor in various ways of local administration in a rat model. Indian J Plast Surg. 2012;45(1):102-108. doi: 10.4103/0970-0358.96596
- Zhang F, Brooks D, Chen W, Mustain W, Chen MB, Lineaweaver WC. Improvement of venous flap survival by application of vascular endothelial growth factor in a rat model. Ann Plast Surg. 2006;56(6):670-673. doi: 10.1097/01.sap.0000203998.37851.57
- Qi C, Lin Y, Lin D. The effect of Shu Xue Tong treatment on random skin flap survival via the VEGF-Notch/Dll4 signaling pathway. J Invest Surg. 2020;33(7):615-620. doi: 10.1080/08941939.2018.1551948
- McCourt M, Wang JH, Sookhai S, Redmond HP. Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg. 1999;134(12):1325-1331; discussion 1331-1332. doi: 10.1001/archsurg.134.12.1325
- Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009;153(2):347-358. doi: 10.1016/j.jss.2008.04.023
- Anderson K, Hamm RL. Factors that impair wound healing. J Am Coll Clin Wound Spec. 2012;4(4):84-91. doi: 10.1016/j.jccw.2014.03.001
- Buttle GAH, Stephenson D, Smith S, Dewing T, Foster GE. The treatment of streptococcal infections in mice with 4:4’diaminodiphenylsulphone. Lancet. 1937;229:1331-1334. doi: 10.1016/S0140-6736(00)75868-5
- Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M. Update on the use of dapsone in dermatology. Int J Dermatol. 2020;59(7):787-795. doi: 10.1111/ijd.14761
- Harvath L, Yancey KB, Katz SI. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones. J Immunol. 1986;137(4):1305-1311.
- Debol SM, Herron MJ, Nelson RD. Anti-inflammatory action of dapsone: Inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction. J Leukoc Biol. 1997;62(6):827-836. doi: 10.1002/jlb.62.6.827
- Abe M, Shimizu A, Yokoyama Y, Takeuchi Y, Ishikawa O. A possible inhibitory action of diaminodiphenyl sulfone on tumour necrosis factor-alpha production from activated mononuclear cells on cutaneous lupus erythematosus. Clin Exp Dermatol. 2008;33(6):759-763. doi: 10.1111/j.1365-2230.2008.02864.x
- Karpel-Massler G, Kast RE, Siegelin MD, et al. Anti-glioma activity of dapsone and its enhancement by synthetic chemical modification. Neurochem Res. 2017;42:3382-3389. doi: 10.1007/s11064-017-2378-6
- Wang C, Cai Y, Zhang Y, Xiong Z, Li G, Cui L. Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression. PLoS One. 2014;9(6):e100818. doi: 10.1371/journal.pone.0100818
- Jafari RM, Shayesteh S, Ala M, et al. Dapsone ameliorates colitis through TLR4/NF-kB pathway in TNBS induced colitis model in rat. Archi Med Res. 2021;52(6):595-602. doi: 10.1016/j.arcmed.2021.03.005
- Rashidian A, Rashki A, Abdollahi A, et al. Dapsone reduced acetic acid-induced inflammatory response in rat colon tissue through inhibition of NF-kB signaling pathway. Immunopharmacol Immunotoxicol. 2019;41(6):607-613. doi: 10.1080/08923973.2019.1678635
- Deng C, Wu B, Wei Z, Zhang Z, Zhang T, Wang D. A systematic study of vascular distribution characteristics and axis design of various flap types. Med Sci Monit. 2019;25:721-729. doi: 10.12659/MSM.911940
- McFarlane R, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg. 1965;35(2):177-182. doi: 10.1097/00006534-196502000-00007
- Van den Heuvel MGW, Buurman WA, Bast A, van der Hulst RRW. Review: Ischaemia-reperfusion injury in flap surgery. J Plast Reconstr Aesthet Surg. 2009;62(6):721-726. doi: 10.1016/j.bjps.2009.01.060
- Aryannejad A, Gandominejad A, Tabary M, et al. Protective effect of modafinil on skin flap survival in the experimental random-pattern skin flap model in rats: The role of ATP-sensitive potassium channels and nitric oxide pathway. J Plast Reconstr Aesthet Surg. 2021;74(6):1346-1354. doi: 10.1016/j.bjps.2020.10.084
- Tabary M, Aryannejad A, Noroozi N, et al. Ivermectin increases random-pattern skin flap survival in rats: The novel role of GABAergic system. J Surg Res. 2021;259:431-441. doi: 10.1016/j.jss.2020.09.010
- Im J, Kong TH, Choi JS, et al. Non-invasive postoperative monitoring of pedicled rat skin flap using laser speckle contrast imaging. Microvasc Res. 2020;132:10405. doi: 10.1016/j.mvr.2020.104050
- Cetinkale O, Bilgic L, Bolayirli M, Sengul R, Ayan F, Burcak G. Involvement of neutrophils in ischemia-reperfusion injury of inguinal island skin flaps in rats. Plast Reconstr Surg. 1998;102(1):153-160. doi: 10.1097/00006534-199807000-00024
- Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol. 1999;277(3):R922-R929. doi: 10.1152/ajpregu.1999.277.3.R922
- Chen F, Wang D, Jiang Y, Ma H, Li X, Wang H. Dexmedetomidine postconditioning alleviates spinal cord ischemia-reperfusion injury in rats via inhibiting neutrophil infiltration, microglia activation, reactive gliosis and CXCL13/CXCR5 axis activation. Int J Neurosci. 2021;133:1-12. doi: 10.1080/00207454.2021.1881089
- Zhang P, Yue K, Liu X, et al. Endothelial Notch activation promotes neutrophil transmigration via downregulating endomucin to aggravate hepatic ischemia/reperfusion injury. Sci China Life Sci. 2020;63(3):375-387. doi: 10.1007/s11427-019-1596-4
- Perry BC, Soltys D, Toledo AH, Toledo-Pereyra LH. Tumor necrosis factor-α in liver ischemia/reperfusion injury. J Invest Surg. 2011;24(4):178-188. doi: 10.3109/08941939.2011.568594
- Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res. 2014;306(2):103-124. doi: 10.1007/s00403-013-1409-7
- Modschiedler K, Weller M, Wörl P, von den Driesch P. Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sections. Arch Dermatol Res. 2000;292(1):32-36. doi: 10.1007/pl00007458
- Suda T, Suzuki Y, Matsui T, et al. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol. 2005;152(5):887-895. doi: 10.1111/j.1365-2133.2005.06559.x
- Zalewska A, Napieralska-Krzysiek E. [Dapsone in skin diseases]. Pol Merkur Lekarsk. 2003;15(89):484-486.
- Khalilzadeh M, Shayan M, Jourian S, Rahimi M, Sheibani M, Dehpour AR. A comprehensive insight into the anti-inflammatory properties of dapsone. Naunyn Schmiedebergs Arch Pharmacol. 2022;395(12):1509-1523. doi: 10.1007/s00210-022-02297-1
- Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus erythematosus: Update of therapeutic options part II. J Am Acad Dermatol. 2011;65(6):e195-e213. doi: 10.1016/j.jaad.2010.06.017
- Stannard JN, Kahlenberg JM. Cutaneous lupus erythematosus: Updates on pathogenesis and associations with systemic lupus. Curr Opin Rheumatol. 2016;28(5):453-459. doi: 10.1097/bor.0000000000000308
- Kozub P, Simaljakova M. Hidradenitis suppurativa treated with combination of infliximab and dapsone. Bratisl Lek Listy. 2012;113(5):319-323. doi: 10.4149/bll_2012_074
- Geyfman M, Debabov D, Poloso N, Alvandi N. Mechanistic insight into the activity of a sulfone compound dapsone on Propionibacterium (Newly Reclassified as Cutibacterium) Acnes-mediated cytokine production. Exp Dermatol. 2019;28(2):190-197. doi: 10.1111/exd.13869
- Köstler E, Wollina U. Ulcerated necrobiosis lipoidica: A combined treatment approach with dermatosurgery and PUVA. Int J Low Extrem Wounds. 2003;2(4):243-245. doi: 10.1177/1534734603260680
- Erfurt-Berge C, Heusinger V, Reinboldt-Jockenhöfer F, Dissemond J, Renner R. Comorbidity and therapeutic approaches in patients with necrobiosis lipoidica. Dermatology. 2022;238:148-155. doi: 10.1159/000514687
- Kwon MJ, Joo HG. Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production. J Vet Sci. 2018;19(6):744-749. doi: 10.4142/jvs.2018.19.6.744
- Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol. 2020;42(3):272-279. doi: 10.1080/08923973.2020.1755308
- Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, Emami AH, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol. 2020;85(3):563-571. doi: 10.1007/s00280-019-04019-6
- Kast RE, Lefranc F, Karpel-Massler G, Halatsch ME. Why dapsone stops seizures and may stop neutrophils’ delivery of VEGF to glioblastoma. Br J Neurosurg. 2012;26(6):813-817. doi: 10.3109/02688697.2012.674577
- Kast RE. Dapsone as treatment adjunct in ARDS. Exp Lung Res. 2020;46(5):157-161. doi: 10.1080/01902148.2020.1753266
- Kast RE, Hill QA, Wion D, et al. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumour Biol. 2017;39(5):1010428317699797. doi: 10.1177/1010428317699797
- Qian LW, Fourcaudot AB, Yamane K, You T, Chan RK, Leung KP. Exacerbated and prolonged inflammation impairs wound healing and increases scarring. Wound Repair Regen. 2016;24(1):26-34. doi: 10.1111/wrr.12381
- Ellis S, Lin EJ, Tartar D. Immunology of wound healing. Curr Dermatol Rep. 2018;7(4):350-358. doi: 10.1007/s13671-018-0234-9
- Harder Y, Amon M, Laschke M, et al. An old dream revitalised: Preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury. J Plast Reconstr Aesthet Surg. 2008;61(5):503-511. doi: 10.1016/j.bjps.2007.11.032
- Hosnuter M, Babucçu O, Kargi E, Altinyazar C. Dual preconditioning: Effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg. 2003;50(4):398-402. doi: 10.1097/01.SAP.0000037261.84618.7F
- Gözü A, Poda M, Taskin EI, et al. Pretreatment with octreotide modulates iNOS gene expression, mimics surgical delay, and improves flap survival. Ann Plast Surg. 2010;65(2):245-249. doi: 10.1097/SAP.0b013e3181c1fe8f